Hello and Welcome to Patientsville.com, Your Source for all JANTOVEN information. We are dedicated to provide You with JANTOVEN safety information. Learn about JANTOVEN serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
JANTOVEN Safety Reports
Total JANTOVEN reports: 12.JANTOVEN FDA safety alerts: No.
Reported deaths: 1 Reported hospitalizations: 7.
Take JANTOVEN Side Effects Survey or Share Your JANTOVEN Story. Read More Here.
Pharmacist from UNITED STATES reported JANTOVEN problem on Jan 02, 2007. Female patient, 54 years of age, weighting 224.9 lb, was diagnosed with pulmonary embolism and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: gangrene, skin discolouration, skin necrosis. JANTOVEN dosage: unknown. Patient recovered.
JANTOVEN problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 18, 2007. Male patient, 78 years of age, was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: headache, prothrombin time abnormal, subdural haematoma. JANTOVEN dosage: unknown. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported JANTOVEN problem on Feb 06, 2007. Female patient, 82 years of age, weighting 145.0 lb, was diagnosed with atrial fibrillation and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, asthenia, cardiac arrest, cerebral haemorrhage, faeces discoloured, hallucination, international normalised ratio increased, post procedural haemorrhage. JANTOVEN dosage: 2.5MG 1X D ORAL. Patient died on 12/07/2006.
JANTOVEN problem was reported by a Physician from UNITED STATES on Apr 09, 2007. Male patient, 58 years of age, was diagnosed with thrombosis, parkinson's disease and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: asthenia, dysstasia, insomnia, international normalised ratio increased, muscle rigidity, pain, restlessness. JANTOVEN dosage: unknown. During the same period patient was treated with WARFARIN, COMTAN, TRIHEXYPHENIDYL, SINEMET, SINEMET CR, AMBIEN, REQUIP, CALCIUM CHLORIDE. Patient recovered.
Pharmacist from UNITED STATES reported JANTOVEN problem on May 15, 2007. Male patient was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: blood disorder, international normalised ratio abnormal. JANTOVEN dosage: unknown. Patient was hospitalized. Patient recovered.
JANTOVEN problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 01, 2006. Female patient was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio increased. JANTOVEN dosage: 1 MG 1 DAILY ORAL. During the same period patient was treated with WARFARIN. Patient recovered.
Pharmacist from UNITED STATES reported JANTOVEN problem on Nov 02, 2006. Female patient, weighting 203.0 lb, was diagnosed with embolism and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: urticaria. JANTOVEN dosage: 6 MG ONCE A DAY PO. Patient recovered.
JANTOVEN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2006. Female patient, 27 years of age, weighting 220.0 lb, was diagnosed with antiphospholipid syndrome and was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio abnormal, intra-abdominal haemorrhage, prothrombin time abnormal. JANTOVEN dosage: 10 MG M-W-F PO ; 7.5 MG SA-SU-TU-TH PO. Patient was hospitalized. Patient recovered.
Consumer or non-health professional from UNITED STATES reported JANTOVEN problem on Nov 27, 2006. Male patient was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: blood disorder, international normalised ratio abnormal, prothrombin time abnormal. JANTOVEN dosage: unknown. Patient was hospitalized. Patient recovered.
JANTOVEN problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 27, 2006. Female patient was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio abnormal, intra-abdominal haemorrhage, prothrombin time abnormal. JANTOVEN dosage: unknown. Patient was hospitalized. Patient recovered.
Pharmacist from UNITED STATES reported JANTOVEN problem on June 19, 2007. Male patient, 24 years of age, was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: international normalised ratio decreased. JANTOVEN dosage: 20 MG, QD, PO. During the same period patient was treated with LOVENOX, PEPCID, VICODIN, NOVOLIN R, PHENERGAN, BACTRIM DS. Patient was hospitalized. Patient recovered.
JANTOVEN problem was reported by a Pharmacist from UNITED STATES on June 19, 2007. Male patient was treated with JANTOVEN. After drug was administered, patient experienced the following problems/side effects: blood sodium decreased, hyperglycaemia, international normalised ratio decreased. JANTOVEN dosage: 10 MG, QD, PO. During the same period patient was treated with FLOMAX, METOPROLOL SUCCINATE, ATIVAN, AVAPRO, NOVOLIN, REGULAR INSULIN, TYLENOL. Patient was hospitalized. Patient recovered.